Merck Executive Vice President and President for Human Health Frank Clyburn will leave the company Feb. 1.
The Kenilworth-based drugmaker announced Clyburn’s exit on Jan. 20; according to Merck, he is leaving to take up a leadership post with another company.
“I am extremely appreciative of Frank’s significant contributions to our company during his 14 years with Merck. Frank has been a key catalyst for value creation, an incredible business strategist, a dedicated people leader and a fierce advocate for patients everywhere,” said Chief Executive Officer and President Robert Davis in a prepared statement.
“Frank’s strategic and operational excellence helped establish Merck as a global leader in oncology. Our human health business has delivered strong and sustainable growth under Frank’s leadership, and we are well-positioned to continue this momentum with the strong human health team we have in place,” he said.
Merck will make an announcement regarding leadership of its Human Health department in the coming weeks.
Clyburn joined Merck in 2008, holding several leadership positions with increasing responsibility throughout his tenure. He was named president of human health in March 2021.
Before that, Clyburn was chief commercial officer for human health and president of the company’s global oncology business.